Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive perspective. Proponents often highlight the potential for meaningful therapeutic benefits, especially in conditions where conventional treatments have proven limited. However, crucially important to assess the significant financial burden associated with CPI s